Back

Anticoagulation strategies and clinical outcomes in atrial fibrillation patients developing renal deterioration during DOAC therapy

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation in atrial fibrillation: safety and outcomes Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

6 More presentations in this session

Presentation thumbnail
Atrial fibrillation and frailty related variance in anticoagulation administration among patients with suspected ischaemic heart disease: the AFRAAID, SWEDEHEART study
Doctor S. Ingves (Norrkoping, SE)
Abstract Slides Video
Presentation thumbnail
Timing of anticoagulation therapy resumption among non-valvular atrial fibrillation (NVAF) patients with prior intracranial haemorrhage
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Net clinical benefit of continued oral anticoagulants after successful AF ablation: a nationwide cohort study
Doctor B. Joung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
D-dimer: a less invasive way to rule out left atrial thrombus
Doctor S. Taerahkun (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Anemia and thrombocytopenia in patients with atrial fibrillation: a nationwide study.
Doctor M. Heikkinen (Helsinki, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation in atrial fibrillation: safety and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation
27 August 2022
thumbnail
Congress Presentation
Association of diabetes mellitus status and clinical outcomes of edoxaban in patients with atrial fibrillation: a sub-analysis from the ETNA-AF Asian registry
12 April 2026
thumbnail
Congress Presentation
Direct oral anticoagulants versus left atrial appendage closure in elderly patients (>80) with atrial fibrillation: results from a propensity matched analysis in real-life patients
28 August 2020
thumbnail
Congress Presentation
Meta-analysis comparing impact of age, sex and renal function on the efficacy and safety of new oral anticoagulants vs. vitamin K antagonists for the treatment of acute venous thromboembolisms
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources